In this Global Business Reports interview, Adare Pharma Solutions CEO Tom Sellig shares insights on the evolving CDMO landscape, including growth drivers, supply chain challenges, and emerging opportunities in areas like pediatrics and high-potency drug development. Drawing on decades of industry experience, Sellig highlights how strategic investment, global expansion, and a focus on innovation are positioning Adare to meet the changing needs of pharmaceutical partners.